about
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powere...
Read More
3.21
-0.10
(-3.02%)
97,779
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Adagene Inc (ADR) is on 23 Sep 2026 for the purpose of Adagene Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Adagene Inc (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..